LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Kodu・Aktsiate loetelu・ResMed Inc

ResMed Inc

Suletud

Sektor Tervishoid

244.63 0.16

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

244.02

Max

245.2

Põhinäitajad
By Trading Economics
Sissetulek	-8.3M 292M
Müük	20M 1.2B
P/E Sektori keskmine	29.45 103.001
Aktsiakasum	2.08
Kasumimarginaal	23.954
EBITDA	-67M 362M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	-9 downside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	24. okt 2024
Järgmine dividendimakse kuupäev	19. sept 2024

Turustatistika
By TradingEconomics
Turukapital	72M 36B
Eelmine avamishind	244.47
Eelmine sulgemishind	244.63

Uudiste sentiment

By Acuity

40%

60%

63 / 365 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

173.1 / 175.28 Toetus ja vastupanu

ResMed Inc Graafik

Seotud uudised

24. juuni 2024, 17:43 UTC

Suurimad hinnamuutused turgudel

Shares of ResMed, Inspire Medical Down After Eli Lilly Provides Sleep Apnea Study Update

27. juuni 2024, 16:01 UTC

Tulu

ResMed Stock Is Down Because of GLP-1 Concerns. It Shouldn't Be. -- Barrons.com

24. juuni 2024, 17:28 UTC

Suurimad hinnamuutused turgudel

ResMed, Inspire Medical Shares Down After Eli Lilly Provides Sleep Apnea Study Update

26. apr 2024, 20:12 UTC

Tulu

These Stocks Moved the Most Today: Alphabet, Microsoft, Intel, Snap, Exxon, Roku, Skechers, ResMed, and More -- Barrons.com

26. apr 2024, 20:09 UTC

Tulu

How 'Megatrends' Like Weight-Loss Drugs And Smartwatches Are Bolstering ResMed -- IBD

26. apr 2024, 14:01 UTC

Tulu

ResMed Soars To Eight-Month High As Quarterly Report Wipes Out Weight-Loss Woes -- IBD

29. jaan 2024, 05:30 UTC

Tulu

ResMed CEO: Weight-Loss Drugs Aren't Cutting Demand for Sleep Apnea Treatment -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

ResMed Inc Prognoos

Hinnasiht

By TipRanks

-9% langus

12 kuu keskmine prognoos

Keskmine 222.75 USD -9%

Kõrge 240 USD

Madal 206 USD

Põhineb 10 Wall Streeti analüütiku instrumendi ResMed Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

10 ratings

Osta

Hoia

Müü

Põhineb 10 analüütiku instrumendi ResMed Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

173.1 / 175.28Toetus ja vastupanu

Bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

63 / 365 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest ResMed Inc

ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep apnea, chronic obstructive pulmonary disease (COPD), neuromuscular disease and other chronic diseases. The Company operates through two segments: Sleep and Respiratory Care segment, and the Software-as-a-Service (SaaS) segment. Sleep apnea includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes ventilation devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions.